candesartan cilexetil has been researched along with naringin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurunath, S; Nanjwade, BK; Patil, PA | 1 |
| K Nanjwade, B; Patil, PA; Surampalli, G | 1 |
| Chilla, R; Nanjwade, BK; Patil, PA; Surampalli, G | 1 |
3 other study(ies) available for candesartan cilexetil and naringin
| Article | Year |
|---|---|
Oral bioavailability and intestinal absorption of candesartan cilexetil: role of naringin as P-glycoprotein inhibitor.
Topics: Administration, Oral; Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B; Benzimidazoles; Biological Availability; Biphenyl Compounds; Flavanones; Intestinal Absorption; Male; Rabbits; Tetrazoles | 2015 |
Corroboration of naringin effects on the intestinal absorption and pharmacokinetic behavior of candesartan cilexetil solid dispersions using in-situ rat models.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Biological Availability; Biphenyl Compounds; Excipients; Flavanones; Freeze Drying; Intestinal Absorption; Male; Rats; Rats, Wistar; Tetrazoles | 2015 |
Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Benzimidazoles; Biological Availability; Biphenyl Compounds; Chemistry, Pharmaceutical; Drug Delivery Systems; Excipients; Flavanones; Hardness; Male; Rabbits; Solubility; Tablets; Tetrazoles | 2016 |